Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Åberg M
JSON
CSV
XLSX
TXT
Family name
Åberg
Given name
Mikael
Initials
M
ORCID
ORCID
0000-0002-7858-8233
Affiliations
Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden.
12 publications
PubMed
DOI
Crossref
Plasma protein profiling predicts cancer in patients with non-specific symptoms.
Wannberg F
,
Álvez MB
,
Qvick A
, ...,
Rosell A
,
Thålin C
Nat Commun
17
(1) 151 [2025-12-29; online 2025-12-29]
PubMed
DOI
Crossref
A human pan-disease blood atlas of the circulating proteome.
Álvez MB
,
Bergström S
,
Kenrick J
, ...,
Edfors F
,
Uhlén M
Science (New York, N.Y.)
390
(6779) eadx2678 [2025-12-18; online 2025-12-18]
Adil Mardinoglu
SciLifeLab Fellow
PubMed
DOI
Crossref
Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics.
Sissala N
,
Babačić H
,
Leo IR
, ...,
Åberg M
,
Pernemalm M
Commun Chem
8
(1) 327 [2025-11-04; online 2025-11-04]
PubMed
DOI
Crossref
Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study.
Blomdahl J
,
Åberg M
,
Fridén M
, ...,
Ekstedt M
,
Vessby J
Scand. J. Gastroenterol.
60
(6) 597-605 [2025-06-00; online 2025-04-16]
PubMed
DOI
Crossref
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.
Chen P,
Bergman P
, Blennow O, ..., Aleman S,
Ljunggren HG
EBioMedicine
109
(-) 105385 [2024-11-00; online 2024-10-11]
DOI
Crossref
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
Marking U
,
Bladh O
, Aguilera K, ...,
Sheward DJ
, Thålin C
-
-
(-) - [2023-12-21; online 2023-12-21]
PubMed
DOI
Crossref
Next generation pan-cancer blood proteome profiling using proximity extension assay.
Álvez MB
,
Edfors F
,
von Feilitzen K
, ...,
Fagerberg L
,
Uhlén M
Nat Commun
14
(1) 4308 [2023-07-18; online 2023-07-18]
Adil Mardinoglu
DDLS Fellow
Fredrik Edfors
SciLifeLab Fellow
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J. Intern. Med.
291
(1) 72-80 [2022-01-00; online 2021-09-27]
PubMed
DOI
Crossref
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
Siegbahn A, Lindbäck J, Hijazi Z, ..., Yusuf S, Wallentin L
J. Thromb. Haemost.
19
(11) 2726-2737 [2021-11-00; online 2021-08-24]
PubMed
DOI
Crossref
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
Wallentin L
,
Eriksson N
,
Olszowka M
, ...,
Åberg M
,
Siegbahn A
PLoS Med.
18
(1) e1003513 [2021-01-00; online 2021-01-13]
PubMed
DOI
Crossref
Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M
, Edén D, Siegbahn A
Apoptosis
25
(7-8) 519-534 [2020-08-00; online 2020-05-28]
PubMed
DOI
Crossref
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J
,
Lampinen M
,
Åberg M
, ...,
Wanders A
,
Carlson M
Ups. J. Med. Sci.
124
(4) 238-245 [2019-11-00; online 2019-11-27]
SciLifeLab Data Centre
Publications
9.5.1